Mechanism of PTEN deficient breast cancer detailed, suggesting improved therapeutics
A group of researchers led by the Dana-Farber Cancer Institute, Boston, has illustrated the mechanistic pathway for PTEN-deficient breast cancer and successfully tested a method of countering the downstream effects of immune ...